Company Overview
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
Key Highlights
- Medical - Pharmaceuticals · Healthcare
- Led by Hermann Lübbert
- 89 employees
- Based in Woburn, MA
Price History
Loading…
Data from Twelve Data. Prices may be delayed.
Analyst Coverage
View All Coverage →No analyst coverage available.
Economic Calendar
View more →- Nov 17
G.17 - Industrial Production and Capacity Utilization
9:15 AM ET
Crypto Prices
View more →
Bitcoin (BTC)
68,236 −4.38%
Ethereum (ETH)
1,927 −4.47%
Solana (SOL)
78 −4.36%
Company Facts
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Headquarters
- Woburn, MA, US
- Incorporated
- Oct 29, 2021
- Website
- www.biofrontera-us.com
Latest SEC Filings
View All Filings →- Quarterly Report (Form 10-Q)Nov 13, 2026